Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haian Fu

Showing results (181-190 of 199) with videos related to

Pageof 20
Sort By:
Nature Communications|March 8, 2025
Uncovering the rewired IAP-JAK regulatory axis as an immune-dependent vulnerability of LKB1-mutant lung cancerChangfa Shu, Jianfeng Li, Jin Rui, et al.
Journal of Medicinal Chemistry|March 15, 2018
Insights into the Action of Inhibitor Enantiomers against Histone Lysine Demethylase 5AJohn R Horton, Xu Liu, Lizhen Wu, et al.
Nature Communications|July 18, 2018
In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancerCaitlin L Grzeskowiak, Samrat T Kundu, Xiulei Mo, et al.
Nature Communications|February 17, 2017
The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategiesZenggang Li, Andrei A Ivanov, Rina Su, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAMFrances M Bashore, Vittorio L Katis, Yuhong Du, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 5, 2023
Development of constitutively synergistic nanoformulations to enhance chemosensitivity in T-cell leukemiaJames M Kelvin, Madison L Chimenti, Dan Y Zhang, et al.
Journal of Medicinal Chemistry|November 6, 2018
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5AJohn R Horton, Clayton B Woodcock, Qin Chen, et al.
Plos One|February 15, 2024
Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAMFrances M Bashore, Vittorio L Katis, Yuhong Du, et al.
Cancer Research|April 7, 2017
Modulation of Bax and mTOR for Cancer TherapeuticsRui Li, Chunyong Ding, Jun Zhang, et al.
Cell Reports|March 14, 2024
Frequency-potency analysis of IgG+ memory B cells delineates neutralizing antibody responses at single-cell resolutionMichelle K Tenggara, Seo-Ho Oh, Catherine Yang, et al.
Pageof 20

Showing results (181-190 of 199) with videos related to

Sort By:
Pageof 20
Nature Communications|March 8, 2025
Uncovering the rewired IAP-JAK regulatory axis as an immune-dependent vulnerability of LKB1-mutant lung cancerChangfa Shu, Jianfeng Li, Jin Rui, et al.
Journal of Medicinal Chemistry|March 15, 2018
Insights into the Action of Inhibitor Enantiomers against Histone Lysine Demethylase 5AJohn R Horton, Xu Liu, Lizhen Wu, et al.
Nature Communications|July 18, 2018
In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancerCaitlin L Grzeskowiak, Samrat T Kundu, Xiulei Mo, et al.
Nature Communications|February 17, 2017
The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategiesZenggang Li, Andrei A Ivanov, Rina Su, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAMFrances M Bashore, Vittorio L Katis, Yuhong Du, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 5, 2023
Development of constitutively synergistic nanoformulations to enhance chemosensitivity in T-cell leukemiaJames M Kelvin, Madison L Chimenti, Dan Y Zhang, et al.
Journal of Medicinal Chemistry|November 6, 2018
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5AJohn R Horton, Clayton B Woodcock, Qin Chen, et al.
Plos One|February 15, 2024
Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAMFrances M Bashore, Vittorio L Katis, Yuhong Du, et al.
Cancer Research|April 7, 2017
Modulation of Bax and mTOR for Cancer TherapeuticsRui Li, Chunyong Ding, Jun Zhang, et al.
Cell Reports|March 14, 2024
Frequency-potency analysis of IgG+ memory B cells delineates neutralizing antibody responses at single-cell resolutionMichelle K Tenggara, Seo-Ho Oh, Catherine Yang, et al.
Pageof 20